Delisting risk
GlucoTrack (GCTK)
Clinical developer of a knee-pain biologic and implanted glucose monitoring.
$3.56
Pre-market+0.04 (+0.99%)
At close$3.53(−4.21%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions12 holders · as of Mar 31, 2026 | 1.34% | 10.7K shares | |
| Insiders7 holders · as of Oct 7, 2025 | 0.50% | 4.0K shares | |
| Strategic holders2 holders · as of Sep 2, 2026 | 10.37% | 82.8K shares | |
| Otherremainder | 87.79% | 700.7K shares |
798.1K company shares as of Sep 1, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (705.3K in the company's Sep 3, 2026 report, 798.1K elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
12 holders · 159.9K shares · 3 new positions · 6 increased · 0 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 47.0K | 5.89% | +47.0Knew | May 15, 2026 |
| Ikarian Capital, LLC | 45.8K | 5.74% | 0 | May 15, 2026 |
| HRT Financial LP | 40.6K | 5.09% | +40.6Knew | May 14, 2026 |
| Boothbay Fund Management, LLC | 13.5K | 1.69% | 0 | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 4.7K | 0.59% | +4.7Knew | May 8, 2026 |
| Alerus Financial Na | 4.0K | 0.50% | 0 | May 12, 2026 |
| Tower Research Capital LLC (TRC) | 3.4K | 0.43% | +3.0K | May 15, 2026 |
| UBS Group AG | 702 | 0.09% | +583 | May 5, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| White Lion Capital LLC | 9.99% | 79.7K | 13G | Sep 2, 2026 ↗ |
| Drew Sycoff | 5.86% | 13G | Sep 10, 2024 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
